Erratum: Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function [Cardiovasc Diabetol, 16 (2017) (58)] DOI: 10.1186/s12933-015-0326-9;Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function

Cardiovascular Diabetology

Volumn 15, Issue 1, 2016, Pages

  Chen, Chang Chiang ^a,b   Susanto, Hendra ^a   Chuang, Wen Han ^a   Liu, Ta Yu ^a   Wang, Chih Hong ^a  

^a NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

ACR; Betatrophin; Diabetic nephropathy; EGFR; Type 2 diabetes

Indexed keywords

ALBUMIN; BETATROPHIN; C REACTIVE PROTEIN; CHOLESTEROL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIVER PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; LIPASIN PROTEIN, HUMAN; PEPTIDE HORMONE;

ADULT; ALBUMINURIA; ALCOHOLISM; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE HOMEOSTASIS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY FUNCTION; MACROALBUMINURIA; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN DIET; RISK FACTOR; SMOKING; SYSTOLIC BLOOD PRESSURE; BLOOD; BLOOD PRESSURE; CASE CONTROL STUDY; COMPLICATION; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; ENZYME LINKED IMMUNOSORBENT ASSAY; KIDNEY; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PATHOPHYSIOLOGY; STATISTICAL MODEL; UPREGULATION; URINE;

ALBUMINURIA; BIOMARKERS; BLOOD PRESSURE; BODY MASS INDEX; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PEPTIDE HORMONES; RISK FACTORS; TRIGLYCERIDES; UP-REGULATION;

EID: 84953313780     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/s12933-017-0538-2     Document Type: Erratum

References (35)

1. Dinesh Shah A, Langenberg C, Rapsomaniki E, Denaxas S, Pujades-Rodriguez M, Gale CP, et al. Type 2 diabetes and incidence of a wide range of cardiovascular diseases: a cohort study in 1.9 million people. Lancet. 2015;385(suppl 1):S86.
2. Svensson M, Eriksson JW. Insulin resistance in diabetic nephropathy-cause or consequence? Diabetes Metab Res Rev. 2006;22:401-10.
3. Hadjadj S, Pean F, Gallois Y, Passa P, Aubert R, Weekers L, et al. Different patterns of insulin resistance in relatives of type 1 diabetic patients with retinopathy or nephropathy: the genesis France-Belgium Study. Diabetes Care. 2004;27:2661-8.
4. Espes D, Martinell M, Carlsson PO. Increased circulating betatrophin concentrations in patients with type 2 diabetes. Int J Endocrinol. 2014;2014:323407.
5. Tessari P, Kiwanuka E, Millioni R, Vettore M, Puricelli L, Zanetti M, et al. Albumin and fibrinogen synthesis and insulin effect in type 2 diabetic patients with normoalbuminuria. Diabetes Care. 2006;29:323-8.
6. Jang CM, Hyun YY, Lee KB, Kim H. Insulin resistance is associated with the development of albuminuria in Korean subjects without diabetes. Endocrine. 2015;48:203-10.
7. Wang Y, Quagliarini F, Gusarova V, Gromada J, Valenzuela DM, Cohen JC, Hobbs HH. Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis. Proc Natl Acad Sci USA. 2013;110:16109-14.
8. Chen X, Lu P, He W, Zhang J, Liu L, Yang Y, et al. Circulating betatrophin levels are increased in patients with type 2 diabetes and associated with insulin resistance. J Clin Endocrinol Metab. 2015;100:E96-100.
9. Yamada H, Saito T, Aoki A, Asano T, Yoshida M, Ikoma A, et al. Circulating betatrophin is elevated in patients with type 1 and type 2 diabetes. Endocr J. 2015.
10. Yi P, Park JS, Melton DA. Betatrophin: a hormone that controls pancreatic beta cell proliferation. Cell. 2013;153:747-58.
11. Espes D, Lau J, Carlsson PO. Increased circulating levels of betatrophin in individuals with long-standing type 1 diabetes. Diabetologia. 2014;57:50-3.
12. Fu Z, Berhane F, Fite A, Seyoum B, Abou-Samra AB, Zhang R. Elevated circulating lipasin/betatrophin in human type 2 diabetes and obesity. Sci Rep. 2014;4:5013.
13. Zhang R, Abou-Samra AB. A dual role of lipasin (betatrophin) in lipid metabolism and glucose homeostasis: consensus and controversy. Cardiovasc Diabetol. 2014;13:133.
14. Fenzl A, Itariu BK, Kosi L, Fritzer-Szekeres M, Kautzky-Willer A, Stulnig TM, et al. Circulating betatrophin correlates with atherogenic lipid profiles but not with glucose and insulin levels in insulin-resistant individuals. Diabetologia. 2014;57:1204-8.
15. Gomez-Ambrosi J, Pascual E, Catalan V, Rodriguez A, Ramirez B, et al. Circulating betatrophin concentrations are decreased in human obesity and type 2 diabetes. J Clin Endocrinol Metab. 2014;99:E2004-9.
16. Ebert T, Kralisch S, Hoffmann A, Bachmann A, Lossner U, Kratzsch J, et al. Circulating angiopoietin-like protein 8 is independently associated with fasting plasma glucose and type 2 diabetes mellitus. J Clin Endocrinol Metab. 2014;99:E2510-7.
17. Hu H, Sun W, Yu S, Hong X, Qian W, Tang B, et al. Increased circulating levels of betatrophin in newly diagnosed type 2 diabetic patients. Diabetes Care. 2014;37:2718-22.
18. Erol O, Ellidag HY, Ayik H, Ozel MK, Derbent AU, Yilmaz N. Evaluation of circulating betatrophin levels in gestational diabetes mellitus. Gynecol Endocrinol. 2015;31:652-6.
19. Yamada H, Saito T, Aoki A, Asano T, Yoshida M, Ikoma A, et al. Circulating betatrophin is elevated in patients with type 1 and type 2 diabetes. Endocr J. 2015;62:417-21.
20. Fujikawa R, Okubo M, Egusa G, Kohno N. Insulin resistance precedes the appearance of albuminuria in non-diabetic subjects: 6 years follow-up study. Diabetes Res Clin Pract. 2001;53:99-106.
21. Fu Z, Abou-Samra AB, Zhang R. An explanation for recent discrepancies in levels of human circulating betatrophin. Diabetologia. 2014;57:2232-4.
22. Abu-Farha M, Abubaker J, Al-Khairi I, Cherian P, Noronha F, Hu FB, et al. Higher plasma betatrophin/ANGPTL8 level in Type 2 diabetes subjects does not correlate with blood glucose or insulin resistance. Sci Rep. 2015;5:10949.
23. Abu-Farha M, Abubaker J, Noronha F, Al-Khairi I, Cherian P, Alarouj M, et al. Lack of associations between betatrophin/ANGPTL8 level and C-peptide in type 2 diabetic subjects. Cardiovasc Diabetol. 2015;14:112.
24. De Tata V. Age-related impairment of pancreatic Beta-cell function: pathophysiological and cellular mechanisms. Front Endocrinol (Lausanne). 2014;5:138.
25. Guo K, Lu J, Yu H, Zhao F, Pan P, Zhang L, et al. Serum betatrophin concentrations are significantly increased in overweight but not in obese or type 2 diabetic individuals. Obesity (Silver Spring). 2015;23:793-7.
26. McKay GJ, Savage DA, Patterson CC, Lewis G, McKnight AJ, Maxwell AP, et al. Association analysis of dyslipidemia-related genes in diabetic nephropathy. PLoS One. 2013;8:e58472.
27. Lezcano EJ, Inigo P, Larraga AM, Barranquero C, Gimenez I, Osada J. Caloric restriction or telmisartan control dyslipidemia and nephropathy in obese diabetic Zucker rats. Diabetol Metab Syndr. 2014;6:10.
28. Thomas MC, Rosengard-Barlund M, Mills V, Ronnback M, Thomas S, Forsblom C, et al. Serum lipids and the progression of nephropathy in type 1 diabetes. Diabetes Care. 2006;29:317-22.
29. Krolewski AS, Warram JH, Christlieb AR. Hypercholesterolemia-a determinant of renal function loss and deaths in IDDM patients with nephropathy. Kidney Int Suppl. 1994;45:S125-31.
30. Mangili R, Zerbini G, Barlassina C, Cusi D, Pozza G. Sodium-lithium countertransport and triglycerides in diabetic nephropathy. Kidney Int. 1993;44:127-33.
31. Fukami K, Yamagishi S, Ueda S, Okuda S. Role of AGEs in diabetic nephropathy. Curr Pharm Des. 2008;14:946-52.
32. Zhang MH, Feng L, Zhu MM, Gu JF, Jiang J, Cheng XD, et al. The anti-inflammation effect of Moutan Cortex on advanced glycation end products-induced rat mesangial cells dysfunction and high-glucose-fat diet and streptozotocin-induced diabetic nephropathy rats. J Ethnopharmacol. 2014;151:591-600.
33. Tan AL, Forbes JM, Cooper ME. AGE, RAGE, and ROS in diabetic nephropathy. Semin Nephrol. 2007;27:130-43.
34. Zhang R, Abou-Samra AB. Emerging roles of Lipasin as a critical lipid regulator. Biochem Biophys Res Commun. 2013;432:401-5.
35. Zhang R. Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels. Biochem Biophys Res Commun. 2012;424:786-92.